Nestor Sanchez Colon, MD
Dermatopathology · Aibonito, PRNPI 1497716609
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $130 of the $165 with a category attached, or 78.8%. 6 manufacturers reported payments, led by Eli Lilly Export S.A. Puerto Rico Branch at 21.4% of the total.
Across 7 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly Export S.A. Puerto Rico Branch$35
- Pfizer$35
- Sun Pharmaceutical Industries Inc.$34
- Sanofi$25
- AbbVie$19
- PBG Puerto Rico LLC$17
Across 2 payments — averaging $12,289 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Galderma Research & Development, LLC$25K
What the payments were for
- Food & beverage$13079%
- Education$3521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | 2 | $35 |
| Pfizer | 1 | $35 |
| Sun Pharmaceutical Industries Inc. | 1 | $34 |
| Sanofi | 1 | $25 |
| AbbVie | 1 | $19 |
| PBG Puerto Rico LLC | 1 | $17 |
How this compares
Too few dermatopathology providers in Puerto Ricoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 33 | $123,862 |
| Fluocinonide | 691 | $34,858 |
| Fluticasone Propionate | 507 | $16,521 |
| CiclopiroxCiclopirox Olamine | 144 | $12,065 |
| Econazole Nitrate | 224 | $10,399 |
| Ketoconazole | 440 | $9,588 |
| Fluorouracil | 110 | $8,859 |
| Betamethasone Dipropionate | 165 | $5,613 |
| Desonide | 142 | $4,977 |
| Clobetasol Propionate | 82 | $4,860 |
| Calcipotriene | 23 | $3,836 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 37 | $3,369 |
| Ivermectin | 34 | $3,292 |
| Clindamycin Phosphate | 129 | $3,225 |
| Triamcinolone Acetonide | 102 | $3,178 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Aibonito
- Tania Gonzalez SantiagoCaguas$202K
- Alvaro Ramos-RodriguezMayaguez$4K
- Julio Sanchez PontSan Juan$3K
- Carlos Sarriera-LazaroSan Juan$1K
- Jorge Sanchez ColonSan Juan$125
- Marta Torres-QuinonesSan Juan$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.